Antonio Marchetti

<i>EGFR</i> Mutations in Non–Small-Cell Lung Cancer: Analysis of a Large Series of Cases and Development of a Rapid and Sensitive Method for Diagnostic Screening With Potential Implications on Pharmacologic Treatment

Antonio Marchetti, Carla Martella, Lara Felicioni et al. · Journal of Clinical Oncology · 2005 · 793 citations

Medicine, Genetics, Oncology +17

Clinical Features and Outcome of Patients With Non–Small-Cell Lung Cancer Harboring <i>BRAF</i> Mutations

Antonio Marchetti, Lara Felicioni, Sara Malatesta et al. · Journal of Clinical Oncology · 2011 · 561 citations

Medicine, Genetics, Oncology +17

The Hippo effector YAP promotes resistance to RAF- and MEK-targeted cancer therapies

Luping Lin, Amit J. Sabnis, Elton Chan et al. · Nature Genetics · 2015 · 553 citations · Full text

Medicine, Cancer Biology, Oncology +14

Increased <i>MET</i> Gene Copy Number Negatively Affects Survival of Surgically Resected Non–Small-Cell Lung Cancer Patients

Federico Cappuzzo, Antonio Marchetti, Margaret C. Skokan et al. · Journal of Clinical Oncology · 2009 · 551 citations · Full text

Medicine, Molecular Genetics, Oncology +15

2nd ESMO Consensus Conference on Lung Cancer: early-stage non-small-cell lung cancer consensus on diagnosis, treatment and follow-up

Johan Vansteenkiste, Lucio Crinò, Christophe Dooms et al. · Annals of Oncology · 2014 · 495 citations · Full text

Medicine, Oncology, Surgery +16